{"abstract": "Top company executives, painting a rosy financial picture for the future, told investors the bid was far too low.", "web_url": "https://www.nytimes.com/2010/10/23/business/23genzyme.html", "snippet": "Top company executives, painting a rosy financial picture for the future, told investors the bid was far too low.", "lead_paragraph": "The biotechnology company Genzyme argued strenuously on Friday that it was worth far more than the $18.5 billion that the French drug maker Sanofi-Aventis was offering in a hostile bid.", "print_section": "B", "print_page": "7", "source": "The New York Times", "multimedia": [], "headline": {"main": "Genzyme Investors Are Urged to Reject Sanofi Offer as Too Low", "kicker": null, "content_kicker": null, "print_headline": "Genzyme Investors Are Urged to Reject Sanofi Offer as Too Low", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis SA", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 3, "major": "N"}, {"name": "subject", "value": "Biotechnology", "rank": 4, "major": "N"}], "pub_date": "2010-10-23T02:14:38+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/e59f91d4-d362-523a-be76-a2121eb92192", "word_count": 393, "uri": "nyt://article/e59f91d4-d362-523a-be76-a2121eb92192"}